{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:01:37Z","timestamp":1781305297431,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"8965","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1016\/s0140-6736(95)90114-0","type":"journal-article","created":{"date-parts":[[2003,9,17]],"date-time":"2003-09-17T02:31:56Z","timestamp":1063765916000},"page":"1595-1599","source":"Crossref","is-referenced-by-count":237,"title":["Prevention of relapses in systemic lupus erythematosus"],"prefix":"10.1016","volume":"345","author":[{"given":"H.","family":"Bootsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wolters-Dicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gmelig-Meyling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(95)90114-0_BIB1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/03009749109165284","article-title":"Outcome of systemic lupus erythematosus: a study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations","volume":"20","author":"Gripenberg","year":"1991","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB2","first-page":"59","article-title":"The longterm prognosis of lupus nephritis: the impact of disease activity","volume":"20","author":"Goulet","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.1780370309","article-title":"The time-dependence of long-term prediction in lupus nephritis","volume":"37","author":"Esdaile","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"10.1016\/S0140-6736(95)90114-0_BIB4","first-page":"S68","article-title":"Survival and causes of death in systemic lupus erythematosus: eleven year follow-up of an inception cohort","volume":"36","author":"Ward","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJM198806023182203","article-title":"Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus","volume":"318","author":"McCune","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780340803","article-title":"Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only","volume":"34","author":"Steinberg","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0272-6386(12)80741-4","article-title":"Immunosuppressive drug therapy in lupus nephritis","volume":"21","author":"Donadio","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM196803072781004","article-title":"Immunologic factors and clinical activity in systemic lupus erythematosus","volume":"278","author":"Schur","year":"1968","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/S0140-6736(95)90114-0_BIB11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/03009747509095629","article-title":"Longitudinal studies of anti-DNA antibody levels in SLE","volume":"11","author":"Lightfoot","year":"1975","journal-title":"Scand J Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.36.2.157","article-title":"Correlation between levels of DNA antibodies and clinical disease activity in SLE","volume":"36","author":"Davis","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/art.1780220903","article-title":"Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus","volume":"22","author":"Miniter","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.1780220304","article-title":"Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus","volume":"22","author":"Swaak","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005792-198105000-00004","article-title":"Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE)","volume":"60","author":"Lloyd","year":"1981","journal-title":"Medicine"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","article-title":"Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus, a long term, prospective study","volume":"33","author":"ter Borg","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.1990.tb05398.x","article-title":"Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus","volume":"82","author":"ter Borg","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/art.1780080208","article-title":"Steroid therapy in systemic lupus erythematosus based on immunologic considerations","volume":"8","author":"Lange","year":"1964","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(78)90056-6","article-title":"The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study","volume":"64","author":"Appel","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0002-9343(81)90870-6","article-title":"The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study","volume":"70","author":"Jarrett","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","article-title":"Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization","volume":"83","author":"Appel","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SDEDAI: a disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.47.9.740","article-title":"The first international standard for antibodies to double stranded DNA","volume":"47","author":"Feltkamp","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9343(89)80687-4","article-title":"Effect of long-term normalization of serum complement levels on the course of lupus nephritis","volume":"87","author":"Laitman","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780280402","article-title":"Evaluation of factors associated with glucocorticosteroid-induced osteopenia in patients with rheumatic diseases","volume":"28","author":"Dykman","year":"1985","journal-title":"Arthritis and Rheum"},{"key":"10.1016\/S0140-6736(95)90114-0_BIB27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.45.5.359","article-title":"Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus","volume":"45","author":"Swaak","year":"1986","journal-title":"Ann Rheum Dis"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673695901140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673695901140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T04:00:52Z","timestamp":1555300852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673695901140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":27,"journal-issue":{"issue":"8965","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["S0140673695901140"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(95)90114-0","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}